Chemours (CC) to Release Earnings on Monday

Chemours (NYSE:CC) is set to announce its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of $0.32 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Chemours (NYSE:CC) last posted its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.19). The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.53 billion. Chemours had a net margin of 2.16% and a return on equity of 33.21%. Chemours’s revenue was down 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.10 earnings per share. On average, analysts expect Chemours to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Chemours Stock Performance

CC opened at $18.32 on Monday. Chemours has a 1-year low of $15.10 and a 1-year high of $32.70. The stock has a market cap of $2.73 billion, a P/E ratio of -8.44 and a beta of 1.74. The stock’s 50 day simple moving average is $18.99 and its 200 day simple moving average is $22.52. The company has a debt-to-equity ratio of 5.45, a current ratio of 1.89 and a quick ratio of 1.01.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.00 dividend on an annualized basis and a yield of 5.46%. Chemours’s payout ratio is -46.08%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CC. The Goldman Sachs Group cut their price target on Chemours from $29.00 to $23.00 and set a “neutral” rating for the company in a research note on Tuesday, September 3rd. Barclays cut their target price on shares of Chemours from $22.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, September 25th. Royal Bank of Canada lowered their price target on shares of Chemours from $35.00 to $28.00 and set an “outperform” rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. cut their price objective on Chemours from $25.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, August 6th. Finally, BMO Capital Markets increased their target price on Chemours from $30.00 to $32.00 and gave the company an “outperform” rating in a report on Monday, October 7th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $25.38.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.